Raphael Pharmaceutical (RAPH) Annual Balance Sheets

Annual · GAAP · USD millions
Access RAPH quarterly Balance Sheets →
The table below presents a historical view of Raphael Pharmaceutical's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2020)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Other Receivables0.00
Total loans net0.00
Total Current Assets0.05
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Tax Assets, Noncurrent1.99
Deferred, Prepaid and Other Assets, Noncurrent0.00
Total Assets0.05
Liabilities
Accounts Payable0.51
Accrued Liabilities, Current0.34
Short-term Debt0.00
Total Current Liabilities1.49
Long-term debt0.00
Total Long-term Debt0.00
Total Liabilities1.49
Stockholders' Equity
Common Stock Value0.20
Additional Paid In Capital Common Stock8.53
Retained Earnings / Accumulated Deficit-10.17
Common Stockholder's Equity-1.43
Total Stockholder's Equity-1.43
Liabilities & Stockholder's Equity0.05
4 historic quarters locked

Sign in to unlock the full Raphael Pharmaceutical balance sheet history.

About Raphael Pharmaceutical Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-037402

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.